{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:42:52Z","timestamp":1787240572017,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010621","name":"Uniwersytet Medyczny w Lublinie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ejphar.2021.174290","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T03:14:39Z","timestamp":1625109279000},"page":"174290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effect of acute and chronic exposure to lovastatin on the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model"],"prefix":"10.1016","volume":"907","author":[{"given":"Micha\u0142","family":"Tomaszewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Zolkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Plewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanis\u0142aw J.","family":"Czuczwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarogniew J.","family":"\u0141uszczki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174290_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40738-020-00074-3","article-title":"Staging of the estrous cycle and induction of estrus in experimental rodents: an update","volume":"6","author":"Ajayi","year":"2020","journal-title":"Fertil Res Pract"},{"key":"10.1016\/j.ejphar.2021.174290_bib2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1124\/mol.119.117721","article-title":"Phenytoin reduces activity of cardiac ryanodine receptor 2; a potential mechanism for its cardioprotective action","volume":"97","author":"Ashna","year":"2020","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174290_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000134913","article-title":"Une nouvelle m\u00e9thode simple pour explorer l\u2019action \u00abtranquillisante\u00bb: le test de la chemin\u00e9e","volume":"3","author":"Boissier","year":"1960","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2021.174290_bib4","first-page":"103","article-title":"Effects of tamoxifen, mifepristone and cyproterone on the electroconvulsive threshold and pentetrazole-induced convulsions in mice","volume":"54","author":"Borowicz","year":"2002","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174290_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0924-977X(03)00067-1","article-title":"Influence of sexual hormone antagonists on the anticonvulsant action of conventional antiepileptic drugs against electrically- and pentylenetetrazol-induced seizures in mice","volume":"14","author":"Borowicz","year":"2004","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.ejphar.2021.174290_bib6","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1528-1167.2011.03118.x","article-title":"Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers","volume":"52","author":"Bullman","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2021.174290_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035538","article-title":"Mouse estrous cycle identification tool and images","volume":"7","author":"Byers","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174290_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1528-1167.2011.03316.x","article-title":"Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis","volume":"53","author":"Chuang","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2021.174290_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2017.10.016","article-title":"Lovastatin suppresses hyperexcitability and seizure in Angelman syndrome model","volume":"110","author":"Chung","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2021.174290_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jacl.2011.06.007","article-title":"Statins and their influence on brain cholesterol","volume":"5","author":"Cibi\u010dkov\u00e1","year":"2011","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.ejphar.2021.174290_bib11","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1212\/WNL.0b013e3181f96253","article-title":"Statin use and risk of epilepsy: a nested case-control study","volume":"75","author":"Etminan","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2021.174290_bib12","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.eplepsyres.2014.10.004","article-title":"Influence of WIN 55,212-2 on the anticonvulsant and acute neurotoxic potential of clobazam and lacosamide in the maximal electroshock-induced seizure model and chimney test in mice","volume":"108","author":"Florek-Luszczki","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2021.174290_bib13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1212\/WNL.0000000000001814","article-title":"Statin treatment reduces the risk of poststroke seizures","volume":"85","author":"Guo","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2021.174290_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0090-9556(24)15273-7","article-title":"Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver","volume":"27","author":"Jacobsen","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2021.174290_bib15","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejphar.2021.174290_bib16","article-title":"Lovastatin modulates glycogen synthase kinase-3\u03b2 pathway and inhibits mossy fiber sprouting after pilocarpine-induced status epilepticus","volume":"7","author":"Lee","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2021.174290_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neulet.2008.05.112","article-title":"Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death","volume":"440","author":"Lee","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2021.174290_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40263-018-0501-0","article-title":"Effect of statin intensity on the risk of epilepsy after ischaemic stroke: real-world evidence from population-based health claims","volume":"32","author":"Lin","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2021.174290_bib19","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1111\/bcp.13626","article-title":"Statin use associated with lower risk of epilepsy after intracranial haemorrhage: a population-based cohort study","volume":"84","author":"Lin","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174290_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2021.174290_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11940-010-0080-y","article-title":"Antiepileptic drugs and markers of vascular risk","volume":"12","author":"Lopinto-Khoury","year":"2010","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.ejphar.2021.174290_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(91)90075-Q","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models","volume":"8","author":"Loscher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2021.174290_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-1211(91)90041-D","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices","volume":"9","author":"Loscher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2021.174290_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0920-1211(90)90013-L","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. I. The influence of administration vehicles","volume":"7","author":"Loscher","year":"1990","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2021.174290_bib25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1528-1157.2003.32702.x","article-title":"Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis","volume":"44","author":"Luszczki","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2021.174290_bib26","first-page":"782","article-title":"How significant is the difference between drug doses influencing the threshold for electroconvulsions?","volume":"57","author":"Luszczki","year":"2005","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2021.174290_bib27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pbb.2011.01.002","article-title":"Synthetic cannabinoid WIN 55,212-2 mesylate enhances the protective action of four classical antiepileptic drugs against maximal electroshock-induced seizures in mice","volume":"98","author":"Luszczki","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2021.174290_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00210-006-0055-4","article-title":"Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model","volume":"373","author":"Luszczki","year":"2006","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174290_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejphar.2013.10.020","article-title":"Effects of WIN 55,212-2 mesylate on the anticonvulsant action of lamotrigine, oxcarbazepine, pregabalin and topiramate against maximal electroshock-induced seizures in mice","volume":"720","author":"Luszczki","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174290_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.eplepsyres.2009.03.027","article-title":"Anticonvulsant and acute neurotoxic effects of imperatorin, osthole and valproate in the maximal electroshock seizure and chimney tests in mice: a comparative study","volume":"85","author":"Luszczki","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2021.174290_bib31","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1038\/s41598-020-58652-w","article-title":"Statin treatment can reduce incidence of early seizure in acute ischemic stroke: a propensity score analysis","volume":"10","author":"Matsubara","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174290_bib32","doi-asserted-by":"crossref","first-page":"20607","DOI":"10.3390\/ijms151120607","article-title":"Molecular mechanisms underlying the effects of statins in the central nervous system","volume":"15","author":"McFarland","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2021.174290_bib33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.21615","article-title":"Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein","volume":"65","author":"Mintzer","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2021.174290_bib34","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s11011-019-00424-1","article-title":"Neuroprotective effects of lovastatin in the pilocarpine rat model of epilepsy according to the expression of neurotrophic factors","volume":"34","author":"Moradi","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2021.174290_bib35","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/pgmj.75.884.359","article-title":"Efficacy of statin therapy: possible effect of phenytoin","volume":"75","author":"Murphy","year":"1999","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.ejphar.2021.174290_bib36","doi-asserted-by":"crossref","first-page":"107400","DOI":"10.1016\/j.yebeh.2020.107400","article-title":"Statins in primary prevention of poststroke seizures and epilepsy: a systematic review","volume":"112","author":"Nucera","year":"2020","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejphar.2021.174290_bib37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuron.2012.01.034","article-title":"Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome","volume":"77","author":"Osterweil","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2021.174290_bib38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1474-4422(03)00483-6","article-title":"Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs","volume":"2","author":"Patsalos","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2021.174290_bib39","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1111\/bph.15193","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"177","author":"Percie du Sert","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174290_bib40","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","article-title":"Clinically relevant drug interactions with antiepileptic drugs","volume":"61","author":"Perucca","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174290_bib41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4103\/jnrp.jnrp_110_18","article-title":"The effect of statins in epilepsy: a systematic review","volume":"9","author":"Quintana-P\u00e1jaro","year":"2018","journal-title":"J. Neurosci. Rural Pract."},{"key":"10.1016\/j.ejphar.2021.174290_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JAD-2010-101653","article-title":"Simvastatin is the statin that most efficiently protects against kainate-induced excitotoxicity and memory impairment","volume":"24","author":"Ramirez","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejphar.2021.174290_bib43","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1590\/S0004-282X2005000600013","article-title":"Lovastatin reduces neuronal cell death in hippocampal CA1 subfield after pilocarpine-induced status epilepticus: preliminary results","volume":"63","author":"Rangel","year":"2005","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.ejphar.2021.174290_bib44","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/dmd.31.5.533","article-title":"Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products","volume":"31","author":"Raucy","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2021.174290_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2012.12.002","article-title":"Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA\/2 mice","volume":"70","author":"Russo","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2021.174290_bib46","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1194\/jlr.M400097-JLR200","article-title":"Lovastatin exacerbates atypical absence seizures with only minimal effects on brain sterols","volume":"45","author":"Serbanescu","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2021.174290_bib47","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/ene.12428","article-title":"Statins are associated with decreased mortality risk after status epilepticus","volume":"22","author":"Sierra-Marcos","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ejphar.2021.174290_bib48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejphar.2011.10.030","article-title":"The interactions of atorvastatin and fluvastatin with carbamazepine, phenytoin and valproate in the mouse maximal electroshock seizure model","volume":"674","author":"Stepien","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174290_bib49","doi-asserted-by":"crossref","first-page":"e2509","DOI":"10.1212\/WNL.0000000000010874","article-title":"Pharmacologic treatment and SUDEP risk: a nationwide, population-based, case-control study","volume":"95","author":"Sveinsson","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2021.174290_bib50","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pneurobio.2009.02.002","article-title":"Statins: mechanisms of neuroprotection","volume":"88","author":"van der Most","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2021.174290_bib51","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/archneurol.2010.199","article-title":"3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases","volume":"67","author":"Willey","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejphar.2021.174290_bib52","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-200241050-00003","article-title":"Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors","volume":"41","author":"Williams","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2021.174290_bib53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jamainternmed.2020.6084","article-title":"Evaluation of time to benefit of statins for the primary prevention of cardiovascular events in adults aged 50 to 75 years: a meta-analysis","volume":"181","author":"Yourman","year":"2021","journal-title":"JAMA Intern. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100443X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992100443X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:16:41Z","timestamp":1762143401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992100443X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":53,"alternative-id":["S001429992100443X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174290","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of acute and chronic exposure to lovastatin on the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174290","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"174290"}}